Dogansen S.C.Cikrikcili U.Oruk G.Kutbay N.O.Tanrikulu S.Hekimsoy Z.Hadzalic A.Gorar S.Omma T.Mert M.Akbaba G.Yalin G.Y.Bayram F.Ozkan M.Yarman S.2024-07-222024-07-2220190021972Xhttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/14505Dopamine agonist (DA)-induced impulse control disorder (ICD) in patients with prolactinomas is not sufficiently known. Objective: To evaluate the prevalence of DA-induced ICDs and possible risk factors related to these disorders in patients with prolactinoma. Design, Setting, and Participants: This is a cross-sectional multicenter study involving 308 patientswith prolactinoma followed up in tertiary referral centers who received at least three months of DA therapy. DA-induced ICDs (pathological gambling, hypersexuality, compulsive shopping, and compulsive eating) and impulsivity were assessed using the Questionnaire for Impulsive- Compulsive Disorders in Parkinson Disease and the Barratt Impulsiveness Scale-11, respectively. Patients were evaluated in terms of parameters related to ICD development. © 2019 Endocrine Society.EnglishAll Open Access; Bronze Open AccessAdolescentAdultAgedCross-Sectional StudiesDisruptive, Impulse Control, and Conduct DisordersDopamine AgonistsFemaleFollow-Up StudiesHumansMaleMiddle AgedPituitary NeoplasmsPrevalenceProlactinomaPsychiatric Status Rating ScalesRisk FactorsSurveys and QuestionnairesYoung Adultbromocriptinecabergolinetestosteronedopamine receptor stimulating agentadolescentadultagedalcohol consumptionArticleattentionawarenessBarratt Impulsiveness Scaleclinical effectivenessclinical evaluationcompulsive buyingcross-sectional studydisease associationdrug efficacyfemalefollow upfood addictionhumanhypersexualityimpulsivenessmajor clinical studymalemulticenter studyParkinson diseasepathological gamblingprevalencepriority journalprolactinomarisk assessmentrisk factorsmokingtertiary care centertestosterone blood levelclinical trialhypophysis tumorimpulse control disordermiddle agedprolactinomapsychological rating scalequestionnaireyoung adultArticle10.1210/jc.2018-02202